Position Statement on Indications of Echocardiography in Adults – 2019

Barberato, Sílvio Henrique; Romano, Minna Moreira Dias; Beck, Adenalva Lima de Souza; Rodrigues, Ana Clara Tude; Almeida, André Luiz Cerqueira de; Assunção, Bruna Morhy Borges Leal; Gripp, Eliza de Almeida; Filho, Fábio Villaça Guimarães; Abensur, Henry; Castillo, José María; Miglioranza, Marcelo Haertel; Vieira, Marcelo Luiz Campos; Barros, Márcio Vinícius Lins; Nunes, Maria do Carmo Pereira; Otto, Maria Estefânia Bosco; Hortegal, Renato de Aguiar; Barretto, Rodrigo Bellio de Mattos; Campos, Thais Harada; Siqueira, Vicente Nicoliello de; Morhy, Samira Saady

doi:10.5935/2318-8219.20190046

Cited by 10 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Echocardiography is an indispensable tool in assessment of ACM; it is under Class I recommendation of updated 'Echocardiography Indication Guidelines' in accordance with the 'Standards for the Elaboration of Guidelines, Positions and Normations' sanctioned by the Brazilian Society of Cardiology in evaluation of a suspected DCM. 27 A study conducted by Fang et al reported LVEF as an independent significant predictor of mortality in univariate analysis of patients with ACM; however, in multivariate analysis, it was found to be insignificant. 28 In our study, patients with an LVEF ≤35% had a higher occurrence all-cause mortality as compared with patients with LVEF >35%, and LVEF was found to be an independent prognostic predictor in patients with ACM.…”

Section: Discussionmentioning

confidence: 96%

Clinical profile and prognostic factors of alcoholic cardiomyopathy in tribal and non-tribal population

et al. 2020

View full text Add to dashboard Cite

ObjectiveAlcoholic cardiomyopathy (ACM) is a leading cause of non-ischaemic dilated cardiomyopathy (DCM) in tribal and non-tribal population. However, no study has been done depicting the correlation between clinical profile and prognosis of ACM in tribal and non-tribal population. This study also defines the long-term outcome and prognostic markers of ACM.MethodsWe studied 290 patients with ACM who were evaluated in our institute between January 2013 and December 2016. The primary endpoint of the study was all-cause mortality. Statistical analysis was done by using Kaplan-Meier survival curves for the assessment of all-cause mortality and Cox regression for the assessment of risk factors.ResultsAfter a median follow-up period of 3.75 years (IQR: 3–4 years), 50 patients with ACM (37.3%) died among tribal population while 14 patients (9%) died among non-tribal population. Independent predictors of all-cause mortality in ACM identified by Cox regression were left ventricular ejection fraction (LVEF) (HR: 0.883; 95% CI 0.783 to 0.996; p=0.043), QRS duration (HR: 1.010; 95% CI 1.007 to 1.017; p=0.005) and Child-Turcotte-Pugh (CTP) Scoring (HR: 12.332; 95% CI 6.999 to 21.728; p<0.001) at admission. The Kaplan-Meier survival probability estimate was 95.1% at 1 year and all-cause mortality was found to be higher in patients with QRS>120 ms, LVEF ≤35%, CTP Grade B/C than patients with QRS≤120 ms, LVEF >35% and CTP Score A, respectively (log-rank χ²=55.088, p<0.001; log-rank χ²=32.953, p<0.001; log-rank χ²=139.764, p<0.001, respectively).ConclusionOur study indicated increased morbidity and mortality in tribal population. LVEF, QRS duration and CTP Scoring at the time of presentation were found to be the independent prognostic markers of patients with ACM.

show abstract

Section: Discussionmentioning

confidence: 96%

Clinical profile and prognostic factors of alcoholic cardiomyopathy in tribal and non-tribal population

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Second, the precision of the technique must be taken into account, especially when assessing the function during dynamic tests or in emergency situations. Nonetheless, TTE is, without doubt, one of the best imaging tools for bedside diagnosis and evaluation of acute cardiovascular conditions [41,58].…”

Section: Cardiac Function Index (Cfi)mentioning

confidence: 99%

Haemodynamic monitoring in acute heart failure – what you need to know

Jasińska-Gniadzik¹,

Szwed²,

Zawadka³

et al. 2022

pwki

View full text Add to dashboard Cite

Acute heart failure (AHF) is a sudden, life-threatening condition, defined as a gradual or rapid onset of symptoms and/or signs of HF. AHF requires urgent medical attention, being the most frequent cause of unplanned hospital admission in patients above 65 years of age. AHF is associated with a 4-12% in-hospital mortality rate and a 21-35% 1-year mortality rate post-discharge. Considering the serious prognosis in AHF patients, it is very important to understand the mechanisms and haemodynamic status in an individual AHF patient, thus preventing end-organ failure and death. Haemodynamic monitoring is a serial assessment of cardiovascular function, intended to detect physiologic abnormalities at the earliest stages, determine which interventions could be most effective, and provide the basis for initiating the most appropriate therapy and evaluate its effects. Over the past decades, haemodynamic monitoring techniques have evolved greatly. Nowadays, they range from very invasive to non-invasive, from intermittent to continuous, and in terms of the provided parameters. Invasive techniques contain pulmonary artery catheterization and transpulmonary thermodilution. Minimally invasive techniques include oesophageal Doppler and noncalibrated pulse wave analysis. Non-invasive techniques contain echocardiography, bioimpedance, and bioreactance techniques as well as non-invasive pulse contour methods. Each of these techniques has specific indications and limitations. In this article, we aimed to provide a pathophysiological explanation of the physical terms and parameters used for haemodynamic monitoring in AHF and to summarize the working principles, advantages, and disadvantages of the currently used methods of haemodynamic monitoring.

show abstract

“…Exemplo: insuficiência cardíaca classe funcional (CF) III ou IV, síncope de provável origem cardíaca, dor torácica, arritmias, acidente vascular cerebral (AVC); suspeita de doença valvar aguda (regurgitação mitral ou aórtica); sintomas agudos em portador de prótese valvar ; suspeita de estenose aórtica grave sintomática sem diagnóstico prévio. 7 • Avaliação antes de terapia clínica urgente, mesmo em paciente assintomático. Exemplo: ecocardiograma basal antes do início de quimioterapia; avaliação da fração de ejeção do ventrículo esquerdo (FEVE) antes de implante de cardiodesfibrilador para prevenção primária.…”

Section: Exames De Alta Prioridade (Essenciais)unclassified

Position Statement on Indications and the Safe Reintroduction of Cardiovascular Imaging Methods in the COVID-19 Scenario – 2021

Lima de Souza Beck,

Barberato,

Cerqueira de Almeida

et al. 2021

Arq Bras Cardiol: Imagem Cardiovasc

Self Cite

View full text Add to dashboard Cite

Position Statement on Indications of Echocardiography in Adults – 2019

Cited by 10 publications

References 0 publications

Clinical profile and prognostic factors of alcoholic cardiomyopathy in tribal and non-tribal population

Clinical profile and prognostic factors of alcoholic cardiomyopathy in tribal and non-tribal population

Haemodynamic monitoring in acute heart failure – what you need to know

Position Statement on Indications and the Safe Reintroduction of Cardiovascular Imaging Methods in the COVID-19 Scenario – 2021

Contact Info

Product

Resources

About